Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A single-walled carbon nanotube (SWCNT) – siRNA complex is a nanotherapeutic delivery system designed to transport small interfering RNA (siRNA) into cells to achieve gene silencing. SWCNTs are one-dimensional carbon nanomaterials that possess unique physical properties, such as high aspect ratios and the ability to penetrate biological membranes via endocytosis or needle-like translocation (Liu et al., 2009, Angewandte Chemie). In this complex, siRNA is typically conjugated to the SWCNT surface through non-covalent interactions like π-π stacking or electrostatic forces, protecting the nucleic acid from enzymatic degradation in the systemic circulation (Lamberti et al., 2011, Nanomedicine). Upon entering the cytoplasm, the siRNA is released to interact with the RNA-induced silencing complex (RISC), leading to the sequence-specific cleavage of target messenger RNA (mRNA) and the subsequent downregulation of specific proteins (Zhang et al., 2011, Biomaterials). This technology is primarily explored for treating diseases characterized by overexpressed or mutated genes, such as various cancers and viral infections (Al-Jamal et al., 2011, PNAS). However, the clinical application of SWCNT-siRNA complexes is currently limited by concerns regarding the long-term biocompatibility, potential asbestos-like toxicity, and the metabolic clearance of carbon nanotubes from the body (Bianco et al., 2011, Nanomedicine).
The complex facilitates the delivery of siRNA across the plasma membrane; once intracellular, the siRNA is released to bind with the RNA-induced silencing complex (RISC), resulting in the degradation of target mRNA and inhibition of protein translation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Single-walled carbon nanotube – siRNA complex (SWCNT-siRNA) (SWCNT-siRNA).